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This study shows the incorporation of ibuprofen, an anti-inﬂammatory drug, in Langmuir monolayers as
cell membrane models. Signiﬁcant effects were observed for dipalmitoyl phosphatidyl choline (DPPC)
monolayers with relevant changes in the elasticity of the monolayer. Dipalmitoyl phosphatidyl glycerol
(DPPG) monolayers were affected by small concentrations of ibuprofen, from 1 to 5 mol%. For both types
of monolayer, ibuprofen could penetrate into the hydrophobic part of the monolayer, which was con-
ﬁrmed with polarization-modulated infrared reﬂection–absorption spectroscopy (PM-IRRAS). Brewster
angle microscopy (BAM) images showed that ibuprofen prevents the formation of large domains of DPPC.
The pharmacological action should occur primarily with penetration of ibuprofen via electrically neutral
phospholipid headgroups of the membrane.
 2013 Elsevier B.V. All rights reserved.1. Introduction
The cell membrane is a complex system essential for cellular
functions because it mediates interactions between the cell and
its external environment. The differentiation and function, for
example, depend on the composition of lipids in the membrane,
which is the reason why delivery of drugs varies for different cell
types [1–3]. A drug administered orally or injected intravenously
seldom arrives in a speciﬁc target in the body in the appropriate
concentrations to cause the expected therapeutic effect. This is eas-
ily explained by the obstacles of various kinds (anatomical, chem-
ical and biological) that must be overcome before the drug reaches
the target organ or tissue [4,5]. Ibuprofen is a non-steroidal anti-
inﬂammatory drug, with low solubility in water (maximum solu-
bility of 0.011 g/L or 53 lM at 25 C) [6], which displays prolonged
side effects. The inconvenience in the use of ibuprofen is mostly
associated with gastrointestinal complications, since 15 to 30% of
patients using this drug for a long time have gastrointestinal ulcers
and bleeding, in addition to renal dysfunction [7].
Interactions of drugs with cell components involve changes in
the organization of the biological membrane. Therefore, it is essen-
tial to characterize the interaction between drugs and membranes,
particularly obtaining molecular-level information. Currently,
this is normally done with membrane model systems, such as
Langmuir monolayers [8–10] and liposomes [11]. The incorpora-
tion of substances in a Langmuir ﬁlm has varying effects depending
on the substance location, its electrical charge, and the method forll rights reserved.incorporation. Though lipid monolayers are much less complex
than the real biological membranes, they have been useful in mod-
eling the interactions [12,13].
This paper deals with the effects from ibuprofen interacting
with Langmuir monolayers with a zwitterionic phospholipid
(DPPC) and an anionic (DPPG) phospholipid. The monolayers were
characterized using surface pressure, surface potential, Brewster
angle microscopy (BAM), and polarization-modulated infrared
reﬂection absorption spectroscopy (PM-IRRAS) measurements.
The main objective was to identify how ibuprofen affects the
molecular packing, in addition to studying the dependence on
the ibuprofen concentration and type of lipid, so that biological
implications can be drawn as to the mode of action for the drug
and its possible incorporation in drug delivery systems.2. Materials and Methods
Dipalmitoyl phosphatidyl glycerol (DPPG) sodium salt and
dipalmitoyl phosphatidyl choline (DPPC) were purchased from
Avanti Polar Lipids, and analytical grade chloroform and metha-
nol were purchased from Merck. Ibuprofen [a-methyl-4-(2-
methylpropyl) benzeneacetic acid] of the highest purity available
was acquired from Sigma. Figure 1 shows the chemical structure
of DPPC, DPPG, and ibuprofen.
Two methodologies were employed to study interaction be-
tween phospholipids and ibuprofen. The ﬁrst was co-spreading
both components from the same solution, which is suitable to ver-
ify whether the drug can interact with the phospholipid and be
incorporated in liposomes as a carrier for ibuprofen delivery [14].
DPPC and ibuprofen were dissolved in pure chloroform, and a
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Figure 1. Chemical structures of dipalmitoyl phosphatidyl choline (DPPC), dipalmitoyl phosphatidyl glycerol (DPPG), and Ibuprofen.
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solutions containing DPPG. Initially, 40lL of solutions containing
pure phospholipids or phospholipids/ibuprofen mixtures in a range
from 0.1 to 5.0% in mol of ibuprofen were spread on the surface to
obtain a Langmuir monolayer. Milli-Q water at pH of 5.6 and tem-
perature of 21 ± 1 C was used as subphase. After spreading, the
solvent was allowed to evaporate for 10 min. In the second meth-
odology, the ability of ibuprofen at incorporating into the phospho-
lipid monolayers was evaluated with the drug in the subphase at
the following concentrations: 12.5, 25.0 or 50.0 lM. The surface
activity of the drug was also assessed without spreading the phos-
pholipids by compressing the barrier to observe any increase in
surface pressure. All experiments were repeated several times to
ensure reproducibility of the isotherms.
Surface pressure and surface potential measurements were car-
ried out with a Langmuir minitrough from KSV Instruments which
total area is 23,625.00 mm2 in a class 10,000 clean room. The sur-
face pressure p was determined using the Wilhelmy plate method
and the surface potential DV was measured using the vibrating
plate method (frequency 300 Hz) using a KSV Kelvin probe with
both reference and vibrating plate electrodes made of platinum,
and the probe located at approximately 1–2 mm above the water
surface. Film compression using two symmetrically movable barri-
ers was carried out at a constant barrier speed of 10 mmmin1.
The system is computer-controlled, which allows the simultaneous
recording of surface-pressure (p-A) and surface-potential (DV-A)
isotherms.
The ﬁlm morphology was studied with a Brewster angle micro-
scope (BAM), Model BAM2Plus System from Nanoﬁlm Technolo-
gies (NFT - Germany), mounted on the trough apparatus. The
BAM principle is based on the fact that a p-polarized light beam
impinging on the water surface at the Brewster angle is not re-
ﬂected. Therefore, no light reaches a camera placed in the direction
of the reﬂected beam. The Brewster angle is determined by the
refractive index of the two media that form the interface, for exam-
ple, water and air, for a clean water surface [15]. If a Langmuir ﬁlm
is formed, this new interface changes with the refractive indexbeing slightly modiﬁed, producing reﬂection of the light toward
the camera. An image of the interfacial ﬁlm structure is formed
by contrast between regions without ﬁlm (dark regions – without
reﬂection) and spots where the water surface is covered with ﬁlm
molecules (bright regions – reﬂection).
Polarization-modulated infrared reﬂection absorption spectros-
copy (PM-IRRAS) was performed using a KSV PMI550 instrument
(KSV, Finland) at a resolution of 8 cm1 with Langmuir monolayers
obtained by spreading mixtures of phospholipids and ibuprofen 5%
in mol on the aqueous subphase. The experimental setup used was
similar to that described by Pavinatto et al. [16]. The Langmuir
trough was mounted for the light beam reach the monolayer at a
ﬁxed incidence angle of 80. As the incoming light was continu-
ously modulated between s- and p-polarization at a high fre-
quency, the spectra could be measured for the two polarizations
simultaneously. The two channels processing the detected signal
give the differential reﬂectivity spectrum DR=(Rp - Rs)/(Rp + Rs),
where Rp and Rs are respectively the polarized reﬂectivities for
parallel and perpendicular directions to the plane of incidence.
The absorption of the parallel polarized light beam comes mainly
from vertically oriented dipoles, while those oriented horizontally
give rise to absorption of the perpendicularly polarized beam. The
difference of the two spectra thus provides information on ori-
ented vibrational dipoles, which is generally surface speciﬁc as
the molecules in the subphase have random orientation. Since
the spectra were measured simultaneously and the IR spectrum
was divided by the corresponding spectrum of the subphase, the
effect of water vapor was reduced. In the angle used in this work,
positive bands indicate a transition moment preferentially in the
surface plane, whereas negative bands indicate preferential orien-
tation perpendicular to the surface.3. Results and Discussion
The main objective in studies of pharmaceutical drugs interact-
ing with model membranes is to obtain molecular-level
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their physiological activity. The two most important modes of ac-
tion are drug penetration into the membrane, altering the packing
of the lipid bilayer and creating pores [17,18], and changes in the
membrane elasticity induced by the drug [19]. Obviously, the mere
coupling of the drug onto the membrane surface may also have an
effect, but this would probably be not as important as the other
two modes of action. Among the various factors affecting the inter-
action with the drug is the charged state of the membrane, which
is the reason why in several studies use is made of neutral and an-
ionic phospholipids. In most cases, interaction is stronger with
charged lipids [20]. In this analysis, we only considered situations
where the pharmacological action depends directly on the mem-
brane and not on the receptor, because a Langmuir monolayer is
probably not a good model to simulate the action, unless the recep-
tor is included in the experiments.
When co-spread with DPPG monolayers, ibuprofen induced sig-
niﬁcant changes in the surface pressure isotherms at concentra-
tions below 1 mol%. Figure 2 shows the isotherms at various
concentrations, where a non-monotonic behavior is noted as the
ibuprofen concentration changed. For the expansion induced by
the drug was considerable for 0.1 mol%, but decreased for 0.2%
and then increased again higher concentrations. This could be re-
lated to dynamic phenomena such as drug dissolution/incorpora-
tion and its aggregation/disaggregation that is characteristic of
metastable systems. It should be stressed that the isotherm for
neat DPPG is consistent with the literature [21,22]. With regard
to the monolayer elasticity, we used the surface pressure-area iso-
therms to calculate the compressional modulus (C1S ¼ Að@p=@AÞ),
also referred to as equilibrium surface elasticity. The physical
states of monolayers are classiﬁed on the basis of Cs1, as follows:
12.5–50 mN/m, liquid-expanded; 50–100 mN/m, liquid; 100–250
mN/m, liquid-condensed;>250 mN/m, solid [23]. A decrease in
compressibility modulus was observed only at high surface pres-
sures, as indicated in the inset of Figure 2. As we shall discuss later
on, in the pressure region relevant for cell membranes (< 32 mN/
m), there is practically no effect upon incorporating ibuprofen. At
higher ibuprofen concentrations, between 1 and 4 mol% (results
not shown), the changes in the isotherms were within the disper-
sion of the data, which was 0.1 mN m1. It seems that either self-
aggregation or dissolution of the drug may have taken place, thus
resulting in no change in the area per DPPG molecule in the iso-35 40 45 50 55 60 65
0
10
20
30
40
50
60
70
0 10 20 30 40 50 60
0
100
200
300
400
500
600
C
s-
1
π  (mN m-1)
Su
rfa
ce
 P
re
ss
ur
e 
(m
N
 m
-1
)
Mean Molecular Area (Å2)
 DPPG
 DPPG-IBU_0,1%
 DPPG-IBU_0,2%
 DPPG-IBU_0,3%
 DPPG-IBU_0,4%
 DPPG-IBU_0,5%
Figure 2. Surface pressure isotherms of DPPG-Ibuprofen monolayers at various
drug concentrations. Each isotherm represents the media from at least 3 measure-
ments, which error obtained was 0.1 mN m1. Inset: Compressibility modulus Cs1
vs. surface pressure for DPPG monolayers.therms. The changes were signiﬁcant only for 5 mol% for which
there was an increase in the compressibility modulus from 400
mN/m for DPPG to 700 mN/m for ibuprofen co-spread at higher
pressures. The concentrations chosen for the experiments were
based on our prior experience and values used in the literature.
Another interesting feature in the isotherms of Figure 2 is the
lowering of the collapse pressure caused by ibuprofen, which
may be attributed to penetration into the hydrophobic part of
the DPPG monolayer, decreasing the stability of the monolayer,
anticipating the 2D-3D process. Furthermore, considerable effects
could be observed with very small ibuprofen concentrations. This
points to the presence of cooperative effects, analogously to what
has been reported for other drugs, such as dipyridamole [24] and
phenotiazine derivatives [25].
The incorporation of ibuprofen also affected the monolayer sur-
face potential, as shown in Figure 3. The surface potential increases
with ibuprofen co-spread, with a non-monotonic dependence on
concentration that results from the metastability of the monolayer.
The inset depicts the change in the apparent dipole moment calcu-
lated with Equation (1) as the ibuprofen concentration was varied.
Note that at large areas per molecule the surface potential of a neat
DPPG monolayer is negative owing to the contribution from the
electrical double-layer formed by counter-ions in solution with
the negative charge of the DPPG headgroups [26,27]. At high pres-
sures the hydrophobic tails are aligned and the surface potential
becomes positive due to the positive contribution from the molec-
ular dipole moments.
DV ¼ l
A0
þW ð1Þ
where DV is the surface potential, l is the apparent dipole moment,
A is the area per molecule, e0 is the vacuum permittivity [28], andW
is the double-layer contribution.
Since ibuprofen is a weak acid with pKa 4.6 [29], its molecules
are expected to be partially ionized in the monolayer. The degree of
dissociation depends on the pH at the interface, which is lower
than the bulk pH (ca. 6.0) due to the negative double-layer poten-
tial [30]. If a comparison is made with the data for stearic acid,
whose pKa lies between 5 and 5.6 in the bulk [31], the degree of
ionization on a pure water surface will be a few percent. (There
has been some controversy over the values adopted for the pKa
of carboxylic acids. See Ref. [32] for a discussion on the topic).20 40 60 80 100 120 140
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Figure 3. Surface potential isotherms of DPPG-Ibuprofen monolayers at various
drug concentrations. Inset: Ratio between the apparent dipole moment of DPPG-
Ibuprofen (l) and pure DPPG (lo) vs. ibuprofen concentration at different surface
pressures.
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crease in surface potential, but this decrease cannot be very large
because the ibuprofen concentration was very low. For these rea-
sons, the contribution of the ibuprofen dipole moments should
be discarded. Therefore, the change in surface potential may be as-
cribed to alterations in the molecular packing of the DPPG mole-
cules, with an ensuing increase in the normal component of their
dipole moments. A change in packing is consistent with the pene-
tration of ibuprofen molecules deep into the hydrophobic part of
the DPPG monolayer, inferred from the surface pressure isotherms.
The changes in surface potential caused by such small amounts of
ibuprofen can only be explained by effects owing to the interaction
between the drug molecules that affect cooperatively the orienta-
tion of DPPG dipoles. By way of illustration, the presence of 0.5 %
ibuprofen caused l to increase by approximately 8% compared to
the neat DPPG monolayer.
The non-monotonic dependence for the ibuprofen concentra-
tion in both surface pressure and surface potential isotherms for
ibuprofen co-spread with DPPG monolayers was conﬁrmed in the
experiments where neat DPPG monolayers were formed on ibu-
profen-containing aqueous subphases (results not shown). The
incorporation of ibuprofen induced small expansions in the surface
pressure isotherms, but the collapse pressure was little affected,
which indicates the maintenance of the monolayer stability, prob-
ably because of a less extent of drug penetration owing to ionic-
dipole repulsions. In addition, the compressibility modulus was
only affected at high surface pressures, similarly to the data for
the co-spread DPPG-ibuprofen monolayers. These data are there-
fore omitted. The only signiﬁcant change was in the surface poten-
tial isotherms, as the surface potential increased with the
incorporation of ibuprofen. It seems that upon adsorbing from the
subphase the ibuprofen molecules are unable to affect the packing
of DPPG to the same extent as in the co-spread monolayers. There-
fore, not only the collapse pressure is barely altered but the change
in surface potential was entirely different. Because the surface po-
tential depends on the surface charge and orientation of the molec-
ular dipole moments, it is a much more sensitive monolayer
property than the surface pressure. Though with the present data
we cannot identify the changes in molecular orientation responsible
for the increase in DPPG monolayer surface potential upon adsorb-
ing ibuprofen, it is clear that ibuprofen molecules affect the mono-
layer in different ways depending on whether they are co-spread
or adsorbed from solution. We shall return to this point later on
while discussing the biological implications of our ﬁndings.
In contrast to DPPG, monolayers of DPPC were barely affected
by co-spreading small amounts of ibuprofen. The changes in sur-
face pressure and surface potential isotherms for concentrations20 40 60 80 100 120 140
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Figure 4. Surface pressure (a) and surface potential isotherms (b) for mixed DPPC/ib
Compressibility modulus Cs1 vs. surface pressure. (b) Ratio between the dipole momen
surface pressures.up to 0.5 mol% were within the dispersion of the data (results
not shown). However, again differently from DPPG, higher ibupro-
fen concentrations did affect the isotherms, as shown in Figure 4a
and b for surface pressure and surface potential, respectively. It is
noted that the isotherms for neat DPPC agree well with the litera-
ture [33]. In addition to a considerable expansion of the isotherm
at large areas per DPPC molecule, the liquid-expanded (LE) to
liquid-condensed (LC) phase transition was affected signiﬁcantly.
This was also reﬂected in a large change in the compressibility
modulus at surface pressures relevant for cell membranes, as can
be seen in the inset of Figure 4a. The lowering in the modulus
means that ibuprofen made the monolayers much more compress-
ible. Because the monolayer expansion was kept even at high sur-
face pressures, as shown in Figure 4a, the ibuprofen molecules
appear to be inserted in the hydrophobic part of the DPPC mono-
layer, without being expelled upon compressing the monolayer.
The surface potential isotherms in Figure 4b also point to mono-
layer expansion induced by ibuprofen, an effect that increased with
the concentration. Also, the ratio of apparent dipole moments,
l/lo, decreased monotonically with the ibuprofen concentration.
Over the years, distinct models have been used to relate the mea-
sured surface potentials in Langmuir monolayers and the molecu-
lar dipole moments [34–37]. Applying such models requires the
knowledge of the normal component of the dipole moments and
therefore the orientation of the monolayer-forming molecules.
For phospholipids interacting with ibuprofen it is not possible to
obtain such precise knowledge, and therefore no quantitative
treatment can be made of the surface potential data. Nevertheless,
the decrease in the apparent dipole moment induced by ibuprofen
for the DPPC monolayers, as it had not occurred for DPPG, indicates
that ibuprofen does affect the packing of phospholipid molecules.
Therefore, the monotonic expansion of the DPPC monolayer with
ibuprofen analyzed by both, surface pressure and surface potential
isotherms, may be related to the neutral nature of the lipid, that
minimize electrostatic repulsions between lipid and drug, avoiding
dynamic process involving drug aggregating, disaggregating and
dissolution during monolayer compression. Also, the surface pres-
sure of collapse increased with drug incorporation, showing
enhancement of monolayer stability, with compression being pos-
sible until the surface tension almost reaches zero.
While discussing the data for DPPG, we stated that the method-
ology used to incorporate ibuprofen could indeed affect the inter-
action. It seemed that interaction was less strong – at least in terms
of penetration into the DPPG monolayer – when ibuprofen was ad-
sorbed from the subphase, rather than being co-spread. The same
applies to DPPC. In subsidiary experiments with neat DPPC mono-
layers spread on ibuprofen-containing subphases (results not20 40 60 80 100 120 140 160
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pressure isotherms, but the shape of the LE-LC phase transition
was not altered. Moreover, the compressibility modulus was af-
fected to a much lower extent by ibuprofen, in comparison to the
large changes in the co-spread DPPC/ibuprofen monolayers. The
difference in behavior for the ibuprofen incorporation from the
subphase was the dependence on the ibuprofen concentration, as
the expansion did not increase monotonically with the concentra-
tion, similarly to the results reported in [38].
We investigated the effects from co-spread ibuprofen on the
morphology of DPPC monolayers using BAM, whose images are
shown in Figure 5 for a mixed DPPC-Ibuprofen (5% in mol) mono-
layer. In the gas phase, a neat DPPC monolayer displayed small,
scattered domains (a), consistent with the literature [39]. As the
monolayer was compressed, the domains increased in size, and
in the LE-LC phase transition, at 5 mN.m1, large, irregularly
shaped domains appeared (b, c). In particular, phase transition do-
mains are observed in Figure 5d. A continuous increase in domain
density with a solid, almost uniform monolayer is observed at 40
mN.m1 (e). When ibuprofen was co-spread, the change in mor-
phology upon monolayer compression was similar to that for a
neat DPPC monolayer, as can be seen in Figure 5 f through (j).
The major difference lies in the smaller size of the domains, whichappeared in a larger number compared to neat DPPC. Moreover,
even during compression the domains remained small. Analo-
gously to the surface pressure isotherms, the BAM images indi-
cated that the LE-LC phase transition was affected by ibuprofen.
With the compression the domains were joined to form an almost
uniform monolayer (i, j), but the domains still visualized were still
small. The large effect in the domain size is consistent with the
changes in the surface pressure isotherms for DPPC. No distinctive
structures were observable within the resolution of BAM during
the compression of DPPG and DPPG-Ibuprofen ﬁlms so these
images have not been presented.
The large effects caused by ibuprofen when co-spread with
DPPC are in contrast to the results by Jabłonowska et al. [40],
who only observed slight changes in the surface pressure iso-
therms for DPPC-ibuprofen mixtures with mole fraction lower than
36%. Furthermore, larger effects were observed for DPPC monolay-
ers spread on ibuprofen-containing subphases, again in contrast to
our results. Motivated by this discrepancy we repeated our exper-
iments and the reproducibility of the data was good. Therefore, it
was not possible to identify the reason for the differences. One pos-
sible way to solve the discrepancy above is to try and conﬁrm that
ibuprofen interacts with the phospholipids using spectroscopic
techniques. As we shall show below, upon employing PM-IRRAS
we ensured that signiﬁcant effects exist for ibuprofen co-spread
with DPPC and DPPG.
The incorporation of ibuprofen affects the PM-IRRAS spectrum
of a DPPCmonolayer, as shown in Figure 6a. Of particular relevance
was the change in the proﬁle of the band assigned to the antisym-
metric stretching vibration of the methylene group, [ma(CH2)],
around 2920 cm1, which was narrower in the presence of ibupro-
fen. This is signiﬁcant because for phospholipids, the CH2 stretch-
ing mode between 2800 and 3000 cm1 is useful as the
frequency and width of the methylene bands are sensitive to the
conformation of phospholipid acyl chains [41]. Therefore, the
changes observed in the spectra are consistent with the penetra-
tion of ibuprofen into the hydrophobic tails inferred from the sur-
face pressure isotherms.
Figure 6b presents the C = O stretching band at 1740 cm1 for
DPPC monolayer at 30 mN m1 which is according to literature
[42–44]. However, crystals of ibuprofen show an intense C = O
stretching band at 1721 cm1 [45]. The PM-IRRAS spectrum of
the DPPC and ibuprofen 5% in mol mixture at 30 mN m1 shows
a shift to higher wavenumber (1743 cm1) and two shoulders are
attached to this band (Figure 6b). The fact that the spectrum of
the mixture is not a simple superposition of the spectra of DPPC
and ibuprofen reveals that the lipid carbonyl groups are in a differ-
ent environment when the molecules are mixed. The interaction
between ibuprofen and DPPC molecules also appears to have af-
fected H-bonding with water molecules in the neighborhood. This
conclusion was based on the observed shifts to higher wavenum-
bers of the antisymmetric (from 1222 to 1229 cm1) and symmet-
ric (from 1083 to 1087 cm1) P = O stretching vibrations, as shown
in Figure 6c and d, respectively. Arrondo and coworkers investi-
gated the 1000–1300 cm1 region of IR spectrum of DPPC and
other phosphate containing molecules [46]. Two bands have been
assigned to various vibrational modes of DPPC phosphate group,
with maximum wavenumbers at 1086 and 1222 cm1. They also
observed shifts to higher wavenumbers with hydration of DPPC.
It is likely that changes of H-bonding between the phosphate
groups and water molecules are due to ﬁlm disordering caused
by ibuprofen.
Figure 7 shows the PM-IRRAS spectra for monolayers of neat
DPPG and DPPG/ibuprofen, in which the expected bands for the
acyl chains of DPPG appear at 2924, 2900 and 2851 cm1, assigned
respectively to ma(CH2), ms(CH3) and ms(CH2), as shown in Figure 7a.
These bands are according to literature [47]. Similarly to DPPC, a
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ν(C=O)
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Figure 6. PM-IRRAS spectra for DPPC and DPPC/ibuprofen monolayers, with 5 mol% of ibuprofen, at 30 mNm1.
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Figure 7. PM-IRRAS for DPPG and DPPG/ibuprofen monolayers, with 5 mol% of ibuprofen, at 30 mN m1.
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2924 to 2920 cm1 for ma (CH2) when ibuprofen was introduced.
Moreover, for DPPG the intensity of the CH3 symmetric band de-
creased in the presence of ibuprofen indicating the disorder of
hydrophobic tails of the phospholipid. Likewise, ibuprofen de-
creased the order ratio [ms(CH3/ms(CH2)] from 0.78 to 0.19 for
DPPG-drug mixed monolayers, which shows direct inﬂuence of
ibuprofen over the alignment of DPPG. Again, this is consistent
with the penetration of ibuprofen in the hydrophobic tails regionof the DPPG monolayer, as indicated by the surface pressure iso-
therms. Figure 7b shows the stretching vibration band from the
carbonyl group which appears at 1731 cm1. For DPPG monolayers
containing ibuprofen this band is broader with a small shoulder at
1712 cm1 due to the presence of ibuprofen. For the antisymmetric
P = O stretching band a considerable shift, from 1243 to 1226 cm1,
was observed in Figure 7c. According to Hübner and coworkers the
shift of this band to lower wavenumbers points to hydration and a
larger number of H-bonds with water molecules at the air–water
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monolayers appears at 1083 cm1 (Figure 7d), characteristic of hy-
drated phosphate groups in lipids [50]. The slight shift to a lower
wavenumber (1080 cm1) suggests changes in hydrogen bonding
of the phosphate group.3.1. Biological Implications
In the analysis of possible implications for the pharmacological
action of ibuprofen, we shall start with the results from the adsorp-
tion of ibuprofen from the subphase, which is the methodology
closer to the real systems. Obviously, one has to bear in mind that
we can only establish possible correlations, because the membrane
model represented by Langmuir monolayers is very simpliﬁed. The
results discussed here pointed to incorporation of ibuprofen pene-
trating into the hydrophobic part of the Langmuir monolayers, but
with only small changes in the elasticity properties of the mem-
brane. The effects were somewhat larger for the neutral DPPC than
for the anionic DPPG, for larger ibuprofen concentrations, because
ibuprofen molecules are slightly negatively charged. The penetra-
tion does indicate that hydrophobic interactions are also relevant,
in addition to the electrostatic interactions. Furthermore, the ef-
fects did not increase monotonically with the ibuprofen concentra-
tion for DPPG, which means that there is partition of ibuprofen
molecules with the subphase and the formation of dynamic aggre-
gates in the subphase during compression that could not adsorb on
the monolayer.
In the experiments in which ibuprofen and DPPG or DPPC were
co-spread, the most important pharmacological activity would be
based on changes in the elasticity of the membrane. The effects,
however, would be much stronger for DPPC, for which large mono-
layer expansions and lowering of the compressibility modulus
could be observed. The changes in elasticity could be responsible
for the modiﬁcation in monolayer morphology, according to BAM
experiments, where a predominance of small domains was noted
throughout the monolayer compression. The formation of smaller
domains associated to the increase in collapse pressure indicates
the enhancement of monolayer stability due to ibuprofen incorpo-
ration in DPPC monolayers. This difference with DPPG must be
attributed to electrostatic interactions. Possible effects from DPPG,
however, cannot be ruled out because the Langmuir monolayers
were affected by small amounts of ibuprofen. It is likely that the
packing of cell membrane regions with charged phospholipids
would be mediated by ibuprofen through an effect where basically
the membrane is expanded without having its elasticity affected.
The results for co-spread monolayers also serve to infer implica-
tions for drug-delivery systems based on liposomes, since the drug
would have to be trapped into phospholipid bilayers. From our
ﬁndings, it is clear that larger ibuprofen loading can be achieved
with DPPC, whose release may be controlled with the considerable
changes in elasticity. Finally, we should mention that the ibuprofen
concentrations employed in this study are much lower than those
administered to patients, which highlights the importance of the
interaction with the phospholipids and the bioavailability of the
drug if incorporated into liposomes. Indeed, the incorporation of
ibuprofen into DPPC and DPPG liposomes has been demonstrated,
with slow release in layer-by-layer (LbL) ﬁlms [14].4. Conclusions
This paper described the interaction of an anti-inﬂammatory
agent, ibuprofen, with model membrane systems consisting of
DPPC and DPPG monolayers. Ibuprofen expanded the monolayers
in both methods of incorporation, either from the subphase or
when co-spread with the phospholipids. From the surface pressureisotherms, we could infer that ibuprofen penetrated into the hydro-
phobic part of the monolayer, with stronger effects being observed
for DPPC. Penetration was conﬁrmed with PM-IRRAS spectroscopy.
This unusual stronger interaction with an electrically neutral
phospholipid, rather than with the anionic DPPG, can be ascribed
to the electrostatic interactions since ibuprofen molecules should
be at least partially ionized at the pH of the experiments. One
important feature was the large change in monolayer elasticity
for DPPC when ibuprofen was co-spread at the air/water interface.
Moreover, the dependence on the concentration of ibuprofen also
varied with the phospholipid. Signiﬁcant effects were only ob-
served in DPPC when the ibuprofen concentration exceeded
1 mol%. In contrast, for DPPG the ibuprofen effects appeared only
at small concentrations, typical of cooperative effects. The larger
changes induced in the DPPC monolayers were also conﬁrmed by
studying the ﬁlm morphology with BAM images.
With regard to the biological implications, the results presented
here point to a physiological action for ibuprofen with preferential
interaction with electrically neutral regions of the membrane, with
the lipid packing being affected by the penetration of the drug into
the hydrophobic chain regions. When ibuprofen was co-spread
with the phospholipids, the physiological action could result from
a large change in the compressibility modulus, particularly at sur-
face pressures prevailing in a cell membrane. It was also clear from
the overall results that ibuprofen can be incorporated into lipid
structures, as already shown for liposomes in a previous study
[14], which is relevant for further use in drug delivery.
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